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Human Herpesvirus Type 8 DNA Sequences in Cell-Free Plasma and
Mononuclear Cells of Kaposi's Sarcoma Patients
WiDiam J. Barrington, Jr., Omar Bagora, CarlosE. Sosa,
Usa E. Bobrosld, Marianna Baum, XueLan Wen,
Usa Cabral, Gerald E. Byrne,RogerJ. Pomerantz,
and CharlesWood
Department ofMldichle, DMstona ofHematology/Oncology and
MicroblologylImmunology, Department of Nsurology, Untwratty of
Miami School of Medicine, andCedanMldical Center, Miam~ Florida,'
Dorrance H. Hamilton Laboratories, Center for Human Virology,
DMston ofInfectiO/l8 Dtseases, Department ofMedicine, Thomas
Jefferson UnIversity, Phlladelphla, Pemt8)lIvania
Human herpesvirus (HHV) type 8 bas been detectedin bothclassical and AIDS-related Kaposi's
slU'C01Dll, body-cavity lymphomas, and other types of tumors. HHV-8 bas also been detected in
DNA from peripheral blood mononuclear cells (PBMC) of some Kaposi's sarcoma patients and
more readily in Bcellfractions derivedfrom pllllDed cellsubpopu1at1ons. TwopatientswerefoUowed
usingseveral methods: in situhybridization, solutton-based polymerase chain reaction (PeR), and
in situ PCR. HHV-8was Intermittently detectedIn Plasma.and detectioncorrelated with detection
In PBMC. In situ PCR demonstrated HHV-8 sequences in both peripheralblood B lymphocytes
and, to a lesser extent,T lymphocytes. HHV-8mayundergo periodsofviremia whileat other times
It Isundetectable and Infects clrculatlngB cells andsomeT celli.
Nucleic acid sequences of Kaposi's sarcoma (KS)-associ-
&ted herpesvirus or human herpesvirus (HHV) type 8 have
beendetected in bothclassical andAIDS-related forms of KS,
lymphoma, Castleman's disease, and skin cancers from organ
allogra:ft recipients [1-4]. These sequences were alsofound in
DNA extracted from the peripheral blood mononuclear cells
(PBMC) ofsome KSpatients [5,6]. Detection ofHHV-8 se-
quences in PBMC of human immunodeficiency virus (HIV)
type I-seropositive persons also comlates with an inc.teased
risk of development of KS [5]. Preliminary evidence suggests
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that the target cells in PBMC could be B lymphocytes [6].
HHV-8wasalsodetected in episomal fonninB celllymphoma
cell lines by in situ hybridization [7], and more recently, in
microvascular endothelial cells (MVEC) and spindle cells from
KS lesions by in situpolymerase chain reaction (IS-PCR) [8].
We describe 2 patients, followed longitudinally, in whom
HHV-8 was detected in tumor tissues, T and B lymphocyte
fractions, and cell-free plasma.
Materials and Methods
Patients. Twopatients,1withAIDS-associated KSand 1with
posttransplant KS, were followed longitudinally.
PatientA was a 34-year-old man with AIDS (CDC stage IV)
who presented with visceromegaly, diffuse adenopathy, and an
elevated lactate dehydrogenase of 1100 U/dL. A lymph node bi-
opsy revealed KS mixed with areas consistent with angioimmu-
noblastic lymphadenopathy. The patient was treatedwith intrave-
nous foscarnet for 2 weeks, resulting in gradualdiminution of his
tumor and normalization of his lactate dehydrogenase level [9].
After discontinuation of foscamet, his tumor slowly reappeared..
The patient's sen:un was tested for the presence of Epstein-Barr
virus (BBV) antibody and was negative. In addition, the PBMC
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were also tested for EBV gene sequences by PCR (HCLF-i, imme-
diate-early gene) and shown to be negative (not shown).
Patient B was a 49-year-old Hlv-Iv-scronegative man who had
had a renal transplant 7 years earlier for end-stage renal disease.
He was taking immunosuppressive drugs (cyclosporine, azathio-
prine, and prednisone) and, 3 years after transplant, developed
lower-extremity cutaneous lesions, which proved to be KS on
biopsy. Reduction in the immunosuppressive therapy resulted in
slight improvement of his tumor. The patient's PBMC were nega-
tive by PCR for EBV gene sequences.
Solution-based PCR. DNA was extracted from PBMC (1-2
X 106) , and tissue biopsies and PCR were done. DNA (500 ng)
was amplified by HHV-8-specific primers (5'-AGCCGAAAG-
GATTCCACCATT-3' and Y-TCCGTGTTGTCTACGTCCAGA-
3'), using published conditions [10] and analyzed on 1% agarose/
ethidium-bromide gels. The predicted size ofthe specific amplified
band was 233 bp (nt 987- 1219 of the published HHV-8 sequence)
[10]. To prepare a cell-free virus pellet, plasma was centrifuged
at 1800 rpm for 15 min to remove cells and further centrifuged at
3500 rpm for 20 min to remove debris. To pellet virus particles,
5 mL of cell-free plasma was centrifuged at 20,000 rpm using a
SW41 Beckman rotor at 4°C for 2 h [11], and pelleted material
was resuspended in PBS. The pellets were treated with DNase at
37°C for 30 min (another aliquot was untreated) to rule out possible
contamination by infected cellular DNA. This treatment was effec-
tive, as it removed any exogenous viral plasmid DNA spiked into
a control serum. DNA from the pelleted viruses was then extracted
by phenol, followed by ethanol precipitation.
In situ PCR and hybridization. isolated PBMC or sub-
sets (T and B lymphocytes) from both patients were transferred
to salinated slides containing a 20-111111 single well. The cells were
air-dried overnight, dipped in absolute methanol for 5 min, and
then washed twice in IX PBS (Ca~+- and Mg-T-free). Appropriate
concentrations of fluorescein isothiocyanate -conjugated mono-
clonal antibodies directed against T and B cell epitopes, anti-
CD3 and anti-CD I9, respectively, were applied separately to each
individual slide. After a I-h incubation at 37°C, the slides were
heat-fixed at 105°C for lOs and then incubated in 4% paraforrnal-
dehyde for 2 h. Paraformaldehyde was inactivated by incubating
slides in 3x PBS for 10 min; the slides were then washed twice
in I X PBS, for 10 min per wash. These slides were incubated
overnight in 0.03% freshly prepared hydrogen peroxide in 1X
PBS, to quench the endogenous peroxidase activity. These slides
were treated with proteinase K (6 ,ug/mL) at room temperature for
12 min. Proteinase K was inactivated incubating slides on a
heat block at 95°C for 5 min. The HHV-8 DNA was amplified in
situ with primers that anneal to nt 987-1006 and 1200- 1219 [10].
Amplified DNA signals were detected a biotinylated probe,
which anneals at nt 1078- I 102 within the amplicons. In situ hy-
bridization was done at 37°C, using a reaction mixture containing
20 pmol of probe, 50% deionized formamide, 2x SSC (1X stan-
dard saline citrate = 0.15 MNaCI, 0.015 M sodium citrate), lOX
Denhardt's solution, I mg/mL ssDNA, and 0.1% SDS. Amplified
DNA was detected using strepavidin-peroxidase; subsequent color
was developed using 3-amino 9-ethylcarbazole, and counter-
staining was done with Gill's hematoxylin [12, 13]. The percentage
of HHV-8-positive cells was determined by counting at least
10,000 cells/slide by 2 independent observers. All microscopic
analyses were done on coded slides.
Table 1. Detection ofHHV-8 sequences by polymerase chain reac-
tion (PCR) in patient cells and cell-free plasma.
Cell-free
plasma
Time points Date PBMC pellet T cells 13 cells
Kaposi's sarcoma
patient A
1 4-17-95 + +
2 4-24-95 +/-
3 5-2-95
4 5-11-95
5 8-8-95 + +
6 8-29-95 +
7 9-19-95 + + +
Kaposi's sarcoma
patient B
1 7-14-95 + +
2 7-26-95
3 8-16-95
4 9-17-95
NOTE. Cell-free plasma was ultracentrifuged, and pelleted material was
tested forpresence ofHHV-8sequences. PCR was done atselected time points.
when material was available. PBMC, peripheral blood mononuclear cells.
PBMC were separated with immunomagnetic beads coated with
high-affinity monoclonal antibodies (Immunotech, Westbrook,
MA) into T and B lymphocyte fractions, using the manufacturer's
suggested protocol. Fluorescence-activated cell sorting analysis of
the Band T cell fractions demonstrated 95% purity by CD 19
and CD3 positivity, respectively. PBMC of patient B were also
separated by this technique into Band T cell fractions and found
to be 99.5% pure B or T cells. For positive internal controls, the
conserved region ofHLA-DQAI, using primers HLA-DQ-GH26-
27 (Synthetic Genetics, San Diego), was amplified (not shown).
Negative controls for each assay were PBMC from HHV-8-ncga-
tive, HIV-L-seronegative persons. Positive controls contained a
mixture of an HHV-8- infected MVEC developed in our laboratory
(data not shown) mixed with an HHV-8-negative MVEC cell
line containing 10% HHV-8-positive cells. Additional negative
controls involved the use of irrelevant primers and unrelated probes
(e.g., EBV- and cytomegalovirus-specific), as previously reported
[11,12].
Results
Fluctuation in HHV-8 viremia determined by PCR analyses.
Seven blood samples were taken from patient A over 3 months,
and 4 were taken from patient B over 2 months (table I). PCR
was done on both patients' original tumor biopsies, PBMC, and
pelleted plasma (table I). Both tumor biopsies were positive by
PCR. PBMC from patient A were positive for HHV-8 at the
first time point but only weakly positive at the second (table
1). PCR signals were not detected at time points 3 and 4 but
were at the next several time points (table 1). The negative and
positive samples were detected by Southern blot hvbridization,
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Figure 1. A, Solution-based polymerase chain reaction (PCR) of
pelleted viral DNA. 5 mL of patient A's serum was pelleted (see
text). DNA extracted from pelleted material (30 ng) was PCR-ampli-
fled, using 330 Bam fragment primer. A, Ethidium bromide- stained
gel: lane I , 330 Bam fragment, amplified from pelleted viral DNA;
lane 2, negative control; lane 3, positive control. B, Southern blot
analysis of gel, using labeled 330 Bam fragment as probe.
A
B
1 2 3 by standar d in situ hybridization in the 2 patients (0.8%-0.3%;
data not shown). Signals were localized near the nuc lear mem-
brane within the cytoplasm. consistent with the episomal nature
of this virus , as previously described [7].
To determine which subpopulation of monon uclear cells ha r-
bor HH V-8. PBM C from patient A were first separated with
immunomagnetic bead s into T and B lymph ocyte fractions,
and PCR was done on extracted DNA from cac h frac tion (table
1) . HHV-8 signals were repeated ly detected (patient A: time
points 6 and 7) in the B cell fraction; the corresponding T
ce ll fraction was wea kly positi ve (data not shown). This resu lt
supports recent findings of Ambroziac et al. [6] that I-1J-l V-8
signa ls are detected main ly in the B cell fraction. However,
when T and B lymphocyte fractions were analyzed by highly
sensi tive IS-PCR, in which a sing le copy of a gene or frag ment
of a gene can be amp lified in situ [12, 13], some T cells were
also positive , althoug h significantly less (range, 1.2% - 2.2% in
pa tient A and 0.1% - 0.9% in patient B) than in the B ce ll
fraction (range, 39%-48% in patient A and 27% - 33% in pa-
tient E) (figure 2C, D).
using the labeled 233 -bp frag ment as a probe. The detection
of HHV -8 also correlated with relapse and progression of pa-
tient A ' s tum or. Of note , the negative samples were drawn
during foscarnet treatment. PBMC from patient B were posi tive
for HHV-8 sequences in itiall y bu t subsequently became nega-
tive (table I). During this per iod, no trea tme nt was given, and
there was no change in his clini cal status .
In order to study whether a cell-free phase of HH V-8 ex ists,
solution-based PCR was don e directly on plasma samples at
diffe rent time points. Initially , HHV-8 signals were not detect-
able in the plas ma . To increase sensitivity and minimize detec-
tion of contaminating cellular DNA, the virus particles were
pelleted by high-speed centri fugation and treated with DNa se
before DNA extraction and PCR analys is . Strong pos itive sig -
nals were detected in the DNA extracted (30 ng) from the
pelleted virus treated with DNase, as demonstrated by ethid-
ium-brornide gels and by Southern blot analysis of the same
gels, using a rad iolabe led 330 Bam probe (figure lA, E, respec -
tively) . As shown in table 1, HHV-8 signals were detected in
both tre ated and untreated samp les from patient A (time points
1, 5, and 7) and patie nt B (time poi nt 1). PCR resu lts were
negative at other time points (patient A: time points 3 and 4;
patient B : time point 2 and later), when PBMC were also
negative .
Detection and localization ofHHV-8 ill PBMC subsets. To
determine the cell type harboring HHV-8, in situ hybridization
and IS-PCR were done. HH V-8 signa ls were found, by IS-
PCR , in 20% - 30% of the PBMC from patient A and 11% -
23% of those from patient E (figure 2A, B, respective ly). No
such sign als were detected in norm al control PBMC from a
disease -free HIV- I - seronegative person (data not shown) .
There were relatively fewer HHV-8-posit ive PBMC detected
Discussion
Until now, ev idence of H HV-8 sequences in peri pheral blood
ce lls from KS patients has been based on PCR or DNA ex-
tracted from mononuclear cells. We detected HH V-8 signals
by an in situ PCR method in PBMe. Although PCR anal ysis
of panned lymphocyte populations detected signa ls in only the
B cell frac tion, we demonstrated that HH V-8 has a broader
tropi sm and can infect T lymphocytes. 1t is possible that the
HHV -8-positive cells contained in the T cell fraction were
contaminating B cells. However, by combining an immunohis-
tochemi stry assay with in situ PCR [12, 13]. we confirmed that
sma ll percentage s of T cells were indeed infected with HH V-
8 in the PBMC of both our patients. Detection of this sequence
in B cells is consis tent with a recent report of HHV-8- positi ve
B lymphoma cell lines deri ved from body-cavity- associated
lym phomas in AIDS patients [7]. Und er circumstances of se-
vere immunosuppression, infection by I-I1-:rV-8 may directly or
indirectly contribute to tra nsformation of B cells. The direct
role of HHV-8 in the development of body-cavity lymphomas
is complicated by the coinfection of these cells by EBV. Detec-
tion of HHV-8 in plasma from DNase-treated and untreated
samples suggests that the signal mu st originate from intact
virus part icles rath er than from con tam inating infected cellu lar
DNA and that HH V-8 has viremic stages in which cell-free
particle s are found in the circulation. Negative PCR resu lts
from both fractions (plasma and PBMC) at other time points
ind icate that HHV-8 may also go through periods of latency,
when it is extremely difficult to detect by PCR.
The host rang e for HHV-8 has not been clearly defined.
A recent study has dem onst rat ed that the spi nd le and MVEC
of the KS lesion s are po sit ive fo r HH V-8 seque nces by IS-
peR [8]. We have also fo und infection of MVEC, spindle
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Figure 2. In situ po lymeras e chain reaction (PCR) of periphe ral blo od mononuclear ce lls (PB MC) from patient s A (A) and B (B) . Stu dy
used HH V-8 pr imer pa ir for in situ PCR, and subsequently , bio tinylated HH V-8 probe from 330 Bam sequence . A rrows in A and B indicate
cells with positi ve signa l. C, D, In situ PCR pe rfo rm ed on T and B lymphocyte subpopulations from both pat ients. Result s are shown for T
and B lymphoc yte subpopulations isolated by ce ll sort ing fro m patient A. Us ing HHV -8 primer pair for in si tu p eR and then hyb ridizing with
HH V-8- specifi c bio tiny lated probe, evidence of HH V-8 sequenc es is visible (arrow s) in both T (C) and B (D) lymph ocyte subsets . % HH V-
8- infected cells in B lymphocyte fract ions were significa ntly higher (se e text) .
cell s, and various layers of dermis in the tissues of all three
major types of KS (i.e., classic al, African endemic, and
AIDS-associated; unpubli shed data). The data in this report
support the contention that HHV -8 is a unique viral agent
able to infect PBMC with an intermittent viremic phase.
There may be a primary infection of mononuclear cells, fol-
lowed by infection of MVEC or transient viremia and act ive
replication of the virus from latent site(s) during immuno-
suppression. Our findings that infection of PBMC by HEV-
8 may be cyclical could also explain why this agent cannot
consistently be detected within PBMC in all KS patients [5].
It will be important to study a larger longitudinal panel of
patients to determine the relationship between HHV -8 vire-
mia, clini cal status, and progression to the development of
Kaposi ' s sarcoma.
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